8 Wall Street analysts have issued ratings and price targets for Aphria in the last 12 months. Their average 12 month price target is US$8.83, suggesting APHA has a possible upside of 95%.
 
The high price target for APHA is US$11.
The low price target for APHA is US$7.
 
There are currently 8 buy ratings resulting in a consensus rating of "Buy."